Michael Leek

Michael Leek

Company: TCBiopharm

Job title: CEO


Recently presented the ‘Scottish Life-Sciences Entrepreneurial Business Leadership’ award, Michael is CEO of TC BioPharm, developing clinical-stage allogeneic CAR-T  immunotherapies.
Active in the cell therapy sector for 30 years, Michael has developed ten different cell-based products to clinic including the world’s first allogeneic cell therapy to undergo multi-national (EU, US, Canada) phase 3 evaluation when he was previously responsible for moving Intercytex from a pre-clinical startup, to an AIM-listed company.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.